| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/08/2009 | CN101405028A Methods for preparing complex multivalent immunogenic conjugates |
| 04/08/2009 | CN101405027A Intranasal influenza vaccine based on virosomes |
| 04/08/2009 | CN101405026A Yeast-based vaccine for inducing an immune response |
| 04/08/2009 | CN101405025A Tumour vaccine comprising allogeneic or xenogeneic tumour cells |
| 04/08/2009 | CN101405024A Drug-polymer conjugates |
| 04/08/2009 | CN101402961A Method for producing glucoprotein vaccine |
| 04/08/2009 | CN101402956A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402944A EV-71 virus seed, inactivated vaccine for human and method of producing the same |
| 04/08/2009 | CN101402942A PolyLyse-HSP70 fusion protein film modified intestinal cancer cytoma vaccine and method of producing the same |
| 04/08/2009 | CN101402687A Fusion protein with high immunogenicity and uses thereof |
| 04/08/2009 | CN101402686A Antihuman Endoglin single-chain antibody, preparation and uses thereof |
| 04/08/2009 | CN101402685A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402677A Quadrant peptide and uses thereof |
| 04/08/2009 | CN101402674A Functional peptide segment of epididymis protease inhibitors and uses thereof |
| 04/08/2009 | CN101402666A Saponin with immunoadjuvant function, preparation method, vaccine preparation containing the saponin as adjuvant and uses thereof |
| 04/08/2009 | CN101401939A Anti-activated state T cell antibody vaccine for preventing and/or treating immune correlated disease |
| 04/08/2009 | CN101401938A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101401937A Method of preparing coexpression PRRSV ORF5 and ORF6 double-gene nucleic acid vaccine |
| 04/08/2009 | CN101401936A Method of preparing coexpression PRRSV ORF5 and PCV2 ORF2 bivalent nucleic acid vaccine |
| 04/08/2009 | CN101401935A Astragalus polysaccharide adjuvant and uses in type I riemerella anatipestifer inactivated vaccine |
| 04/08/2009 | CN101401934A T cell component vaccine for preventing and/or treating immune correlated diseases |
| 04/08/2009 | CN101401805A Vitamin E supplementation to tetanus toxoid |
| 04/08/2009 | CN100475966C New-type adenovirus with tumor cell specific infection and transgenic expression capability |
| 04/08/2009 | CN100475963C Chicken infectivity bursa of Fabricius virus VP2 cDNA, its expression vector, expressed recombinant protein and application thereof |
| 04/08/2009 | CN100475953C Pancreatic stem cells |
| 04/08/2009 | CN100475849C Tetravalence single chain antibody of p53 tetra polymerized structure domain |
| 04/08/2009 | CN100475848C Anti-TRAIL-R antibodies |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475842C Molecular structure of RHD negative genes locus |
| 04/08/2009 | CN100475265C A chicken Coccidiosis pill form vaccine and preparation method thereof |
| 04/07/2009 | US7514547 Helicobacter felis vaccine |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514538 Compositions and methods for the diagnosis and treatment of tumor |
| 04/07/2009 | US7514536 interleukins produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; polypeptide has anti-hepatitis C activity |
| 04/07/2009 | US7514535 Chimeric immunogens |
| 04/07/2009 | US7514534 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 04/07/2009 | US7514529 Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines |
| 04/07/2009 | US7514397 Administering homologs of peptides corresponding to amino acid residues 638 to 673, and to amino acid residues 558 to 595, of the human immunodeficiency virus-1LAI transmembrane protein glycoprotein 41; inhibiting membrane fusion |
| 04/07/2009 | US7514233 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases |
| 04/07/2009 | US7514224 Arrays of PDZ domain polypeptides |
| 04/07/2009 | US7514090 Monocyte locomotion inhibitory factor |
| 04/07/2009 | US7514089 Mutant Salmonella species with genetically engineered MSBB gene, expresses altered lipid, has reduced inductino of tumor necrosis factor and increased sensitivity to chelating agents; as antitumor agent |
| 04/07/2009 | US7514088 Multivalent Clostridial toxin derivatives and methods of their use |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | US7514086 Peptide-based vaccine for influenza |
| 04/07/2009 | US7514084 isolated nonapeptide that bind to an human leukocyte antigen (HLA-A 0201) restricted T cell receptors with high affinity and induce a high cytotoxic T lymphocyte response, used for treating or preventing tumors and cancers |
| 04/07/2009 | US7514083 Protein allergens of the species cynodon dactylon |
| 04/07/2009 | US7514082 Virus suppressing factor (VSF) for use in treatment and prevention of viral infection in animal and humans |
| 04/07/2009 | US7514081 administering an isolated antibody or an antigen-binding fragment that binds a novel member of the tumor necrosis factor (TNF) family of cytokines, to inhibit TNF- alpha induction |
| 04/07/2009 | US7514080 Drug conjugate composition |
| 04/07/2009 | US7514079 prevention and treatment of cancer as well as immune system diseases and disorders including pre-eclampsia, hypertension, inflammation, asthma, gastrointestinal disorders, anxiety, depression, addiction, or pain; host cell; kits; expression vector |
| 04/07/2009 | US7514078 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 04/07/2009 | US7514077 administering an antibody that binds Interleukins, to neurons, for the treatment of inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in neuronal tissues; antiinflammatory agents; analgesics |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | US7514067 Complexing enzyme with antibody; trapping within tumor |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2410065C Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/07/2009 | CA2389943C Human antibodies that bind human tnf.alpha. |
| 04/07/2009 | CA2313704C Recombinant nodavirus compositions and methods |
| 04/07/2009 | CA2269060C Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/07/2009 | CA2264488C A method for generating birnavirus from synthetic rna transcripts |
| 04/07/2009 | CA2206343C Reagents and processes for targeting mutant epidermal growth factor receptors |
| 04/07/2009 | CA2192659C Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| 04/07/2009 | CA2175332C Haemophilus transferrin receptor genes |
| 04/07/2009 | CA2127262C Somatostatin receptors |
| 04/07/2009 | CA2118239C 1h-imidazo{4,5-c}quinolin-4-amines as vaccine adjuvants |
| 04/07/2009 | CA2117492C Bystander suppression of autoimmune diseases |
| 04/02/2009 | WO2009043051A2 Cd23 binding molecules and methods of use thereof |
| 04/02/2009 | WO2009042962A2 Antidotes for factor xa inhibitors and methods of using the same |
| 04/02/2009 | WO2009042794A2 Venezuelan equine encephalitis replicons expressing paramyxovirus glycoproteins as vaccine |
| 04/02/2009 | WO2009042773A1 Adoptively transferred tumor-specific t cells stimulated ex vivo using herpes simplex virus amplicons |
| 04/02/2009 | WO2009042642A2 Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer |
| 04/02/2009 | WO2009042589A1 Monoclonal antibodies to respiratory syncytial virus and uses thereof |
| 04/02/2009 | WO2009042202A2 Formulations for preservation of rota virus |
| 04/02/2009 | WO2009042165A2 Mutant botulinum neurotoxin serotype a polypeptide and uses thereof |
| 04/02/2009 | WO2009042053A2 Neuromedin u receptor agonists and uses thereof |
| 04/02/2009 | WO2009041734A1 Agonistic antibody against human thrombopoietin receptor |
| 04/02/2009 | WO2009041643A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | WO2009041621A1 Anti-il-6 receptor antibody |
| 04/02/2009 | WO2009041613A1 Modified antibody constant region |
| 04/02/2009 | WO2009041062A1 Anti-glypican-3 antibody having improved kinetics in plasma |
| 04/02/2009 | WO2009041037A1 Drug for suppressing pathogen occurring in vivo |
| 04/02/2009 | WO2009040819A2 DOWN-REGULATION OF MORTALIN BY siRNA |
| 04/02/2009 | WO2009040674A2 A public and immunogenic cd4+ t cell epitope of the hiv tat protein and its applications |
| 04/02/2009 | WO2009040529A1 Bacterial vaccine |
| 04/02/2009 | WO2009040508A2 Methods of detection and enrichment of prpsc by immunoprecipitation and elisa |
| 04/02/2009 | WO2009040443A1 Rna vaccines |
| 04/02/2009 | WO2009040426A1 Immunoliposomes for treatment of cancer |
| 04/02/2009 | WO2009040418A1 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis |
| 04/02/2009 | WO2009040413A2 An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases |
| 04/02/2009 | WO2009040361A1 Vaccine for the treatment of osteoarthritis |
| 04/02/2009 | WO2009040343A1 Inactivated influenza vaccine |
| 04/02/2009 | WO2009040268A1 Fixed single injection dosage for ocrelizumab (2h7) |
| 04/02/2009 | WO2009040134A1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 04/02/2009 | WO2009040131A1 Vv promoter-driven overexpression of recombinant antigens |
| 04/02/2009 | WO2009040075A1 Blockers of serotonin and its receptors for the treatment of hepatitis |
| 04/02/2009 | WO2009039584A1 Diagnosis and treatment of diseased and damaged tissue |
| 04/02/2009 | WO2009023714A3 Compositions and methods for the treatment and prophylaxis of hypertension |
| 04/02/2009 | WO2009015842A3 Novel immunogenic epitopes for immunotherapy |